Form 4: Boston Scientific CFO Reports Stock Transaction
Insider Transaction (Form 4)
Jonathan Monson, EVP and CFO of Boston Scientific Corp, reported a transaction in 9,908 shares of common stock on August 10, 2026.
Summary
- Discretionary transaction: acquired 9,908 Common Stock at $50.46 ($499,958) on August 10, 2026; holds 9,908 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jonathan Monson — Officer (EVP and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Discretionary transaction | Common Stock | 9,908 | $50 | $500.0K | 9,908 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Discretionary transaction (9,908 shares) |
Keywords
insider transaction, Form 4, BSX, BOSTON SCIENTIFIC CORP, neutral, Jonathan Monson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.